Revenue Growth - Total revenues increased by $71.7 million to $347.6 million for the three months ended September 28, 2025, compared to $275.9 million for the same period in 2024, representing a 26.0% increase [138]. - Revenues in the Kratos Government Solutions segment increased by $48.7 million, primarily due to growth in the Defense Rocket Support business and contributions from the recent acquisition of assets from Norden Millimeter, Inc. [138]. - The Unmanned Systems segment reported revenues of $87.2 million for the three months ended September 28, 2025, an increase of $23.0 million from $64.2 million in the same period in 2024, driven by an international shipment of tactical Valkyrie aircraft [138]. - Service revenues for the total company increased by 13.0% to $117.4 million, while product sales rose by 33.8% to $230.2 million [138]. - Total revenues increased by $148.5 million to $1,001.7 million for the nine months ended September 28, 2025, with significant growth in the KGS segment [147]. - Product sales for the nine months ended September 28, 2025, increased by $110.7 million to $647.0 million, accounting for 64.6% of total revenue [148]. Cost and Margin Challenges - Cost of revenues increased by $63.8 million to $270.5 million for the three months ended September 28, 2025, driven by higher labor and material costs [140]. - Gross margin decreased to 22.2% for the three months ended September 28, 2025, down from 25.1% in the prior year, with margins on products and services also declining [141]. - Cost of revenues for the nine months ended September 28, 2025, rose by $141.4 million to $777.2 million, reflecting increased labor and material costs [149]. Operational Challenges - The company faces challenges from supply chain disruptions and inflation, which have increased operational costs and negatively impacted profit margins [133][134]. - A labor shortage in the industry is affecting the company's ability to hire and retain skilled personnel, impacting operational efficiency and margins [134]. Financial Position - As of September 28, 2025, cash and cash equivalents increased to $565.9 million from $329.3 million as of December 29, 2024 [161]. - Total long-term debt decreased from $185.0 million at December 29, 2024 to zero at September 28, 2025, following the extinguishment of all outstanding Term Loan A debt [162]. - Net cash used in operating activities was $54.2 million for the nine months ended September 28, 2025, compared to a net cash provided of $4.1 million for the same period in 2024 [165]. - Net cash used in investing activities was $71.1 million for the nine months ended September 28, 2025, primarily due to capital expenditures [166]. - Net cash provided by financing activities was $360.2 million for the nine months ended September 28, 2025, including net proceeds from the issuance of common stock of approximately $555.9 million [167]. - The company believes that cash on hand, along with the undrawn $200 million revolving credit facility, will be sufficient to fund anticipated working capital needs for at least the next 12 months [172]. Capital Expenditures and Investments - The company is making significant capital investments to address its backlog and opportunity pipeline, including expansions in unmanned jet drone manufacturing and microwave electronics facilities [125]. - Capital expenditures for fiscal year 2025 are expected to be significant, totaling approximately $35 to $40 million, including $25 to $30 million for capital aerial targets and related support equipment [166]. Debt Management - The company extinguished all outstanding Term Loan A debt on July 2, 2025, utilizing proceeds from a public equity offering [168]. - The company incurred a loss of $0.5 million related to the extinguishment of the Term Loan A debt due to the write-off of unamortized debt issuance costs [168]. Market Opportunities - The company is positioned to benefit from a generational recapitalization of weapon systems globally, addressing threats from peer and near-peer adversaries [135]. - The Department of War's budget request for fiscal year 2026 includes approximately $962 billion, reflecting an 11.8% increase or $101.6 billion above fiscal year 2025 levels [127]. - The U.S. government appropriated an additional $156 billion for national security priorities through the One Big Beautiful Bill Act, expected to enhance defense modernization projects [128].

Exhibit 99.1 NEWS RELEASE The Andersons, Inc. Reports Third Quarter Results MAUMEE, OHIO, November 4, 2025 - The Andersons, Inc. (Nasdaq: ANDE) announces financial results for the third quarter ended September 30, 2025. Third Quarter Highlights: "This quarter's results include 100% ownership of our ethanol plants for August and September as a result of the acquisition we completed at the end of July. We are excited to have full control over these strategic assets and are both evaluating and implementing a v ...

Financial Risks - XPLR's substantial amount of indebtedness may adversely affect its ability to operate and execute its business plan[20] - XPLR's long-term debt was approximately $5.9 billion as of September 30, 2025, with 99% not exposed to interest rate fluctuations due to being fixed rate or financially hedged[152] - A hypothetical 10% decrease in interest rates would increase the fair value of XPLR's long-term debt by approximately $94 million[152] - A hypothetical 10% decrease in rates would decrease XPLR's net derivative assets by approximately $48 million[153] - XPLR's future tax liability may exceed expectations if net operating losses (NOLs) are insufficient to offset taxable income[23] - XPLR's ability to use NOLs to offset future income may be limited, and distributions to unitholders may be taxable as dividends[23] Operational Risks - XPLR's renewable energy projects are significantly impacted by weather conditions, which can affect cash flows and operational performance[15] - The company relies on a limited number of customers and vendors, exposing it to credit and performance risks[15] - Changes in government laws and regulations regarding clean energy incentives could negatively impact XPLR's operations[20] - XPLR's ability to develop and acquire assets involves various risks, including project siting and financing challenges[20] - The company may not be able to extend or renew existing power purchase agreements (PPAs) at favorable rates[15] - XPLR's insurance coverage may not protect against all significant losses, impacting its financial stability[15] - The company is subject to environmental, health, and safety regulations that may require significant capital expenditures[15] Competitive Landscape - The company faces competition from regulated utility holding companies and independent power producers in the U.S. market[20] Governance and Structural Risks - XPLR's partnership agreement restricts remedies for common unit holders against breaches of fiduciary duties by directors or XPLR GP[23] - Holders of XPLR's common units cannot remove XPLR GP without NEE's consent, potentially delaying favorable acquisitions[23] - The issuance of common units may dilute ownership and impact the market price of XPLR's common units[23] Credit Risk Management - Credit risk is managed through credit policies and a diversified portfolio of counterparties to mitigate non-performance risks[154]

Financial Performance - Revenue for Q3 2025 was $681 million, representing a 3.5% increase year-over-year[4] - GAAP diluted earnings per share (EPS) for Q3 2025 was $0.39, while non-GAAP diluted EPS was $0.62[4] - The company achieved a gross margin of 10.0% and an operating margin of 3.5% for Q3 2025[4] - The company reported a total operating income of $24 million for Q3 2025[4] - Net income for the nine months ended September 30, 2025, was $18,879,000, a decrease from $44,904,000 in the same period of 2024, representing a decline of approximately 58.1%[17] - Non-GAAP net income for the nine months ended September 30, 2025, was $61,501,000, compared to $61,853,000 in 2024, reflecting a slight decrease of 0.6%[20] - GAAP operating margin for the nine months ended September 30, 2025, was 2.9%, down from 4.0% in the same period of 2024, showing a decline of 27.5%[20] - Non-GAAP operating margin for the nine months ended September 30, 2025, was 4.7%, compared to 5.1% in 2024, representing a decrease of 7.8%[20] - The company reported a GAAP gross profit of $195,895,000 for the nine months ended September 30, 2025, compared to $202,099,000 in 2024, a decrease of about 3.1%[20] Cash Flow and Assets - The cash conversion cycle improved to 77 days in Q3 2025, down from 90 days in Q3 2024[6] - Net cash provided by operating activities for the nine months ended September 30, 2025, was $65,288,000, down from $143,309,000 in 2024, indicating a decrease of about 54.4%[20] - Cash and cash equivalents at the end of the period on September 30, 2025, were $286,061,000, down from $324,423,000 at the end of the previous year, a decline of approximately 11.8%[17] - Free cash flow for the nine months ended September 30, 2025, was $37,334,000, significantly lower than $119,088,000 in 2024, indicating a decrease of about 68.8%[20] Inventory and Expenses - Total inventories as of September 30, 2025, were $48,547,000, a decrease from $102,540,000 in 2024, reflecting a reduction of approximately 52.7%[17] - Stock-based compensation expense increased from $10,740,000 in the nine months ended September 30, 2024, to $15,077,000 in 2025, representing an increase of approximately 40.5%[17] Guidance and Future Outlook - Bookings momentum continued in Q3 2025, positioning the company for growth into 2026 and beyond[3] - Fourth quarter 2025 revenue guidance is projected between $670 million and $720 million[9] - Non-GAAP EPS guidance for Q4 2025 is expected to be between $0.62 and $0.68[9] Sector Performance - The semiconductor capital equipment sector generated $185 million in revenue, accounting for 27% of total revenue in Q3 2025[5] Current Assets - Total current assets decreased to $1,435 million as of September 30, 2025, compared to $1,504 million a year earlier[15]

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-09583 MBIA INC. (Exact name of registrant as specified in its charter) Connecticut (State or other jurisdiction of i ...

Acquisition and Portfolio - As of September 30, 2025, the company acquired 151 properties leased to the USPS for approximately $96.6 million, increasing its portfolio to 1,853 properties [155]. - The company has acquired 19 properties for an aggregate amount of approximately $7.2 million since September 30, 2025 [218]. Financial Performance - Rental income increased by $4.9 million to $23.7 million for the three months ended September 30, 2025, representing a 26.2% increase compared to $18.8 million for the same period in 2024 [178]. - Total revenues for the three months ended September 30, 2025, were $24.3 million, up $4.7 million or 23.7% from $19.7 million in the prior year [178]. - Income from operations rose by $4.4 million to $9.1 million for the three months ended September 30, 2025, reflecting a 91.1% increase from $4.8 million in 2024 [178]. - Net income for the three months ended September 30, 2025, was $4.9 million, a significant increase of $3.5 million or 262.0% from $1.3 million in the same period last year [178]. - For the nine months ended September 30, 2025, rental income increased by $15.2 million to $67.9 million, a 28.7% increase from $52.7 million in 2024 [187]. - Total revenues for the nine months ended September 30, 2025, were $69.8 million, up $14.8 million or 26.9% from $55.0 million in the prior year [187]. - Income before income tax expense for the nine months ended September 30, 2025, was $12.2 million, a 351.5% increase from $2.7 million in 2024 [187]. Expenses and Indebtedness - Total interest expense, net for the three months ended September 30, 2025, was $4.3 million, an increase of $0.8 million or 24.6% from $3.4 million in 2024 [186]. - General and administrative expenses increased by $0.9 million to $13.0 million for the nine months ended September 30, 2025, primarily due to increased public-company related costs [192]. - Real estate taxes increased by $1.1 million to $8.3 million for the nine months ended September 30, 2025, primarily due to the volume of acquisitions [190]. - Depreciation and amortization expense increased by $1.1 million to $17.6 million for the nine months ended September 30, 2025, compared to $16.6 million for the same period in 2024 [194]. - Total interest expense, net increased to $11.9 million for the nine months ended September 30, 2025, from $9.3 million for the same period in 2024, primarily due to additional borrowings [195]. - As of September 30, 2025, the company had approximately $349.2 million of outstanding consolidated principal indebtedness [211]. - The company’s total indebtedness includes a $150.0 million senior unsecured revolving credit facility and a $290.0 million term loan facility [172]. Cash Flow and Financing Activities - Net cash provided by operating activities increased by $8.9 million to $33.2 million for the nine months ended September 30, 2025, compared to $24.3 million for the same period in 2024 [197]. - Net cash used in investing activities for the nine months ended September 30, 2025, was $89.6 million for acquisitions, compared to $53.2 million for the same period in 2024 [198]. - Net cash provided by financing activities increased by $30.2 million to $60.4 million for the nine months ended September 30, 2025, compared to $30.2 million for the same period in 2024 [199]. - The company paid cash dividends of $0.7275 per share for the nine months ended September 30, 2025 [214]. Tax and Regulatory Considerations - The company intends to continue qualifying as a REIT, which generally exempts it from federal income tax as long as it distributes taxable income to stockholders [163]. - New U.S. tax legislation effective July 4, 2025, includes a permanent extension of the 20% deduction for qualified REIT dividends for individuals [164]. Market and Operational Risks - The company is dependent on the USPS' financial stability, which is currently threatened by various operational and financial challenges [165]. - Approximately 10.4% of total rental income for the nine months ended September 30, 2025, was concentrated in Pennsylvania [161]. Lease and Property Management - The average remaining lease term for properties leased to tenants is approximately 4.0 years as of September 30, 2025 [166]. - The company operates primarily through modified double-net leases, where tenants are responsible for utilities and certain maintenance obligations [167]. Interest Rate Management - The company manages market risk on variable-rate debt through interest rate swaps, aiming to reduce floating rate exposure [221]. - If the one-month Adjusted Term SOFR were to change by 1.0%, the company's cash flows would be affected by approximately $0.25 million on an annualized basis [220]. - The fixed interest rate on one loan is 3.69% for the first five years, adjusting thereafter based on the Five-Year Treasury Rate plus a margin of 2.75% [4]. - A loan secured by an industrial property has a fixed interest rate of 2.80% with interest-only payments for the first five years [7]. - The company obtained seller financing of $1.4 million for the acquisition of two properties at a fixed interest rate of 5.00% [8]. - The company has a minimum annual interest rate of 2.75% on certain loans, regardless of market conditions [4]. - The company may use derivative instruments like interest cap agreements in the future to manage interest rate volatility [221]. Capital Projects - The company is currently undertaking capital improvement projects expected to cost between $0.8 million and $1.6 million, with a portion offset by insurance proceeds of $0.4 million received in October 2025 [210].

Revenue Growth - Revenue for Q3 2025 increased by 16% to $8.1 million, marking the highest quarterly revenue in company history and the 19th consecutive quarter of year-over-year revenue growth[1][10][12]. - The Diagnostics segment saw a significant growth of 51%, driven by the adoption of the TRUFORMA® platform and the introduction of a new Development Services revenue stream[5][10][16]. - International sales grew by 16% year-over-year, supported by new distribution agreements and partnerships in key markets[6]. - The introduction of new products, including enhancements to the TRUFORMA® platform and the upcoming TRUVIEW AI platform, is expected to drive future revenue growth[7]. - Zomedica's total addressable market in the U.S. exceeds $2 billion, indicating significant growth opportunities in the animal health sector[21]. Profitability and Expenses - Gross margin for the quarter was reported at 67%, contributing to improved profitability prospects[8][10][13]. - Operating expenses decreased by 4% year-over-year to $12.0 million, reflecting effective cost-reduction initiatives[8][13][14]. - Net loss for Q3 2025 was reduced by 9% to $6.1 million compared to the same period in 2024[15]. - Adjusted Non-GAAP EBITDA loss for the three months ended September 30, 2025, was $3,702 thousand, an improvement from $4,313 thousand in the same period of 2024[31]. - Interest income for the three months ended September 30, 2025, was $(561) thousand, an improvement from $(977) thousand in 2024[31]. Financial Position - The company had cash and cash equivalents of $54.4 million as of September 30, 2025, providing a strong liquidity position to support growth initiatives[18]. - Non-GAAP EBITDA loss for the nine months ended September 30, 2025, was $71,427 thousand, compared to a loss of $34,612 thousand in 2024, indicating a significant increase in losses[33]. - Total net loss for the nine months ended September 30, 2025, reached $77,223 thousand, compared to $39,536 thousand in 2024, reflecting a worsening financial position[33]. Impairment and Expenses - Impairment expense for the nine months ended September 30, 2025, was $55,833 thousand, a substantial increase from $16,024 thousand in 2024[33]. - Stock-compensation expense for the three months ended September 30, 2025, was $868 thousand, up from $473 thousand in the same period of 2024[31]. - Amortization expense for the nine months ended September 30, 2025, was $4,499 thousand, slightly lower than $4,834 thousand in 2024[33]. - Income tax benefit for the nine months ended September 30, 2025, was $(64) thousand, compared to $(336) thousand in 2024, indicating a decrease in tax benefits[33]. Proforma Adjustments - Proforma adjustments for the three months ended September 30, 2025, included $214 thousand, down from $523 thousand in 2024[31].

Exhibit 99.1 UNIFI®, Makers of REPREVE®, Announces First Quarter Fiscal 2026 Results First Quarter Fiscal 2026 Overview "Our first quarter results for fiscal 2026 came in below our expectations, as we continue to navigate headwinds from softer customer ordering patterns amid an uncertain trade environment," said Eddie Ingle, Chief Executive Officer of Unifi, Inc. "While a recovery in the retail industry and trade policy clarity will both take time, our conversations with our customers have remained positive ...

Financial Performance - Total revenues for Q3 2025 were $597.8 million, up from $539.5 million in Q3 2024, representing an increase of approximately 10.5%[3] - U.S. net product revenues from the cabozantinib franchise were $542.9 million, compared to $478.1 million in the same period last year, reflecting a growth of about 13.5%[3] - GAAP net income for Q3 2025 was $193.6 million, or $0.69 per diluted share, compared to $118.0 million, or $0.40 per diluted share in Q3 2024, marking a year-over-year increase of 64%[9] - Non-GAAP net income for Q3 2025 was $217.9 million, or $0.78 per diluted share, compared to $135.7 million, or $0.47 per diluted share in Q3 2024, indicating a growth of approximately 60.6%[10] - Total revenues for the nine months ended September 30, 2025, reached $1.72 billion, compared to $1.60 billion for the same period in 2024, reflecting a 7.5% growth[34] - The company’s net income for Q3 2025 was $193.58 million, up 64.2% from $117.97 million in Q3 2024[34] Expenses - Research and development expenses decreased to $199.2 million in Q3 2025 from $222.6 million in Q3 2024, a reduction of about 10.5%[5] - Selling, general and administrative expenses increased to $123.7 million in Q3 2025 from $111.8 million in Q3 2024, an increase of approximately 10.5%[6] - The company’s operating expenses for Q3 2025 totaled $361.22 million, a decrease from $403.47 million in Q3 2024[34] Stock and Shareholder Returns - Exelixis announced an additional stock repurchase program for up to $750 million by the end of 2026[1] - Exelixis has repurchased $895.3 million of its common stock at an average price of $37.18 per share as of September 30, 2025, returning $1.9 billion to shareholders since March 2023[24] - The weighted-average diluted common shares outstanding decreased from 326.3 million to 278.5 million shares since the first stock repurchase program in March 2023[24] Future Plans and Guidance - Exelixis is providing updated financial guidance for 2025, projecting total revenues between $2.30 billion and $2.35 billion[15] - The company plans to submit a New Drug Application for zanzalintinib in combination with atezolizumab for advanced colorectal cancer by the end of 2025[18] - Exelixis plans to submit a New Drug Application for zanzalintinib in combination with atezolizumab by the end of 2025, pending government service availability[30] Pipeline Development - The cabozantinib franchise generated $542.9 million in net product revenues, with $46.3 million earned in royalty revenues from collaboration partners[16] - Exelixis initiated a phase 1 study of XB371 in August 2025, expanding its early-stage pipeline programs to four ongoing phase 1 trials[23] - Exelixis estimates a federal cash tax benefit of $147 million from the repeal of the requirement to capitalize domestic R&E expenditures, effective for taxable years beginning after December 31, 2024[25]

Revenue and Profitability - Revenue for Q3 2025 was $281.0 million, a decrease of 4.7% compared to $295.0 million in Q3 2024[4] - Gross profit increased by 2.3% to $76.0 million from $74.3 million year-over-year[4] - Operating income rose significantly by 77.4% to $9.4 million, compared to $5.3 million in the same quarter last year[4] - Net loss improved by 63.4% to $4.1 million from a loss of $11.2 million in Q3 2024[5] - Adjusted EBITDA increased by 80.9% to $12.3 million, up from $6.8 million in Q3 2024[5] Sales and Units - Total retail unit sales for powersports increased by 2.2% to 14,605 units, with new powersports sales up 1.7% to 9,904 units[8] - The company reported a significant decline in vehicle transportation services revenue, down 93.4% to $1.0 million from $15.1 million in Q3 2024[9] Cash and Liquidity - Cash (unrestricted) decreased by 58.5% to $35.4 million from $85.3 million at the end of Q4 2024[6] - The company has a total available liquidity of $182.9 million as of September 30, 2025, including cash and credit facilities[10] - Cash and restricted cash at the end of the period was $51.8 million, down from $66.7 million at the end of the previous year, a decrease of approximately 22.4%[23] Debt and Liabilities - Non-vehicle net debt increased slightly by 1.5% to $184.9 million compared to $182.1 million in the previous year[6] - Total current liabilities slightly decreased from $324.4 million as of December 31, 2024, to $319.6 million as of September 30, 2025, a reduction of about 1%[21] - Non-Vehicle Net Debt increased to $184.9 million as of September 30, 2025, compared to $182.1 million as of December 31, 2024, showing a rise of 1.5%[31] - The Consolidated Total Net Leverage Ratio was reported at 4.1x, well below the maximum allowed of 6.75x[37] Overall Performance - Net loss for the nine months ended September 30, 2025, was $46.0 million, compared to a net loss of $22.2 million for the same period in 2024, representing an increase in losses of 106%[23] - Adjusted EBITDA for the nine months ended September 30, 2025, was $36.5 million, up from $30.7 million in 2024, reflecting a growth of 19%[27] - Free Cash Flow for the nine months ended September 30, 2025, was $10.5 million, significantly down from $67.0 million in 2024, indicating a decrease of approximately 84%[30] Impairments and Expenses - SG&A expenses for the nine months ended September 30, 2025, were $192.2 million, down from $211.2 million in 2024, a decline of about 9%[35] - The company incurred an impairment of franchise rights amounting to $34.0 million during the nine months ended September 30, 2025[27] Assets - Total assets decreased from $755.2 million as of December 31, 2024, to $699.4 million as of September 30, 2025, a decline of approximately 7.4%[21]